Tuesday, September 20, 2016 10:53:33 AM
31 mins ·
Itonis, Inc. Signs Facebook Ad Campaign for Its Emesyl Anti-Nausea Homeopathic Product in California Market
LAGUNA HILLS, CA--(Marketwired - September 20, 2016) - Itonis, Inc. (OTC PINK: ITNS) is pleased to announce that it has signed an agreement with Facebook to run online advertisements over a 30-day period in its California Market for its Emesyl® anti-nausea Homeopathic product.
The online advertisements have already started and are designed to target an audience within the state of California who suffer from nausea and nausea-like symptoms.
The Facebook advertisement can be viewed here: http://https://www.facebook.com/65086905831…/posts/1217313255006867
A "Shop Now" button links viewers to the http://https://www.Emesyl.com website for anyone wishing to purchase the Emesyl® anti-nausea product.
"The Facebook ad campaign is another step Itonis is moving forward to create additional branding and retail sales for our anti-nausea Emesyl® product," said Steve Pidliskey, Itonis Vice President.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM